| 摘要 |
PURPOSE: To provide a remedy for ophthalmicus disorders caused by autoimmune diseases, particularly the ophthalmicus disorders caused by Behcet's syndrome, known with malignant symptoms. CONSTITUTION: This therapeutic agent for ophthalmicus disorders caused by autoimmune diseases comprises, as active ingredients, (A) an immunosuppression agent such as dexamethasone, cyclosporin A, rapamycin, FK 506, mizoribine, cyclophosphamide, azathioprine or methotrexate and (B) eicosapentaenoic acid(EPA) and/or docosahexaenoic acid(DHA). The dose of the ingredient B is 70-2,000mg/day as EPA or 100-2,000mg/day as DHA once or several times each day. The ophthalmicus disorders are, for example, uveitis, conjunctivitis, episcleritis, scleritis, retrobulbar neuritis, keratitis or blephalitis. |
